Ragusa R, Russo S, Villari L, Schilirò G
Department of Pediatric Hematology and Oncology, University of Catania, Via Santa Sofia, 78 95123, Catania, Italy.
Pediatr Hematol Oncol. 2001 Sep;18(6):407-14. doi: 10.1080/088800101316922038.
There is a known association between lymphoid malignancy and Hodgkin's disease (HD), but the development of HD in children who have been treated for leukemia or lymphoma is very uncommon. Hodgkin's disease is, after retinoblastoma, the most common primary tumor that is associated with development of second malignant neoplasm. For reasons that remain to be determined, HD is very rare as a second malignancy [1, 2, 3]. We report the case of a eight-year-old girl who developed HD 6 years after treatment for common acute lymphoblastic leukemia (ALL). This case prompted us to review the published literature for cases of secondary HD in childhood. Our experience suggests that we should follow strictly our patients with ALL and be ready to intervene with invasive diagnostic procedures at the least suspicion of a second or recurrent neoplasm. The most frequent causes of second tumors are radiotherapy, genetic susceptibility and prior treatment with certain chemotherapeutic agents, such as nitrogen mustards. It is likely that any type of immunodeficiency, even without symptoms, might play a role in the development of second tumors in childhood.
已知淋巴系统恶性肿瘤与霍奇金病(HD)之间存在关联,但接受过白血病或淋巴瘤治疗的儿童发生HD的情况非常罕见。霍奇金病是继视网膜母细胞瘤之后,与第二原发性恶性肿瘤发生相关的最常见原发性肿瘤。由于尚待确定的原因,HD作为第二原发性恶性肿瘤非常罕见[1,2,3]。我们报告了一名8岁女孩的病例,她在接受普通急性淋巴细胞白血病(ALL)治疗6年后发生了HD。该病例促使我们回顾已发表的关于儿童继发性HD病例的文献。我们的经验表明,对于ALL患者,我们应严格随访,并在至少怀疑有第二原发性或复发性肿瘤时准备好采用侵入性诊断程序进行干预。第二原发性肿瘤最常见的原因是放疗、遗传易感性以及先前使用某些化疗药物(如氮芥)进行治疗。任何类型的免疫缺陷,即使没有症状,都可能在儿童第二原发性肿瘤的发生中起作用。